Pfizer-BioNTech COVID-19 Vaccine Global Information About Pfizer‑BioNTech COVID‑19 Vaccine (also known as BNT162b2 or as COMIRNATY) The approval status of the Pfizer‑BioNTech COVID‑19 Vaccine varies worldwide. For countries where the relevant regulatory authority has not authorised the...
The Pfizer COVID-19 vaccine is 97% effective in preventing symptomatic disease in actual use, which is better than previously thought.
About 45 million people have received one or more shots of thePfizerorModernaCovid-19 vaccine, equal to 13.6% of the U.S. population, according to CDC data. On Wednesday, the U.S. Food and Drug Administration's staff endorsedJohnson & Johnson's one-shot vaccinefor emergency use, a key...
Based on current projections, Pfizer and BioNTech expect to produce up to 50 million vaccine doses in 2020, and up to 1.3 billion doses in 2021. The vaccine requires two doses per person. Though the companies didn't take any money from the federal government for research and...
et al. Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against Covid-19 related symptoms in England: test negative case-control study. Preprint at medRxiv https://doi.org/10.1101/2021.11.15.21266341 (2021). Article PubMed PubMed Central Google Scholar Katiki...
WASHINGTON, March 11 (Xinhua) -- Two doses of Pfizer-BioNTech COVID-19 vaccine greatly reduced the risk of Omicron infection among children aged 5 to 15, according to a study published by the U.S. Centers for Disease Control and Prevention (CDC) on Friday. ...
We are proud to be part of developing the world's first COVID-19 vaccine, which has protected millions globally from this devastating disease. But our work is not done. Fighting COVID-19 requires adjustments to the vaccine to address new variants and provide ongoing protection. We also believ...
Two doses of Pfizer'sCOVID-19 vaccineadjusted in potency for children 5 to 11 years old proved 90.7% effective against symptomatic disease, the company said in documents filed with the government, as U.S. authorities near key decisions on whether to expand use of the shots to younger age ...
Pfizer Inc. said Monday that its COVID-19 vaccine may be a remarkable 90% effective, based on early and incomplete test results that nevertheless brought a big burst of optimism to a world desperate for the means to finally bring the catastrophic outbrea
Study: Pfizer vaccine proves very effective eliminating COVID strains The Pfizer vaccine was able to neutralize a number of COVID variants from different locations worldwide. Video by The Hill